This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing treatment options for Cushing Syndrome and the potential of relacorilant from Corcept Therapeutics

Ticker(s): CORT

Who's the expert?

Institution: Barrow Neurological Institute

  • Neuroendocrinologist and Medical Director of the Barrow Pituitary Center and Neuroendocrinology Clinic.
  • Currently manages ~50 patients with Cushing's Syndrome and has prescribed Recorlev to 6 of them.
  • Clinical and research interests include the diagnosis and treatment of pituitary and adrenal tumors, pituitary dysfunction, growth hormone deficiency and excess, hypogonadism, and cortisol deficiency and excess.

Interview Goal
Discuss outlook for relacorilant in Cushing Syndrome

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.